Liver-directed gene transfer and prolonged expression of three major human apoE isoforms in apoE-deficient mice

Journal of Clinical Investigation

Volumn 100, Issue 1, 1997, Pages 107-114

  Tsukamoto, Kazuhisa ^a   Smith, Pearle ^a   Glick, Jane M ^a   Rader, Daniel J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenoviral vector; ApoE isoform; Gene transfer; Hyperlipeproteinemia; Lipoprotein metabolism

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; GENE EXPRESSION; GENE TRANSFER; HYPERLIPOPROTEINEMIA; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030857810     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119501     Document Type: Article

References (38)

1. Mahley, R.W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (Wash. DC). 240:622-630.
2. Beisiegel, U. 1995. Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism. (Review.) Curr. Opin. Lipidol. 6:117-122.
3. Nathan, B.P., S. Bellosta, D.A. Sanan, K.H. Weisgraber, R.W. Mahley, and R.E. Pitas. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science (Wash. DC). 264:850-852.
4. Strittmatter, W.J., and A.D. Roses. 1995. Apolipoprotein E and Alzheimer disease (Review.) Proc. Natl. Acad. Sci. USA. 92:4725-4727.
5. Ghiselli, G., E.J. Schaefer, P. Gascon, and H.B. Breser, Jr. 1981. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (Wash. DC). 214:1239-1241.
6. Mabuchi, H., H. Itoh, M. Takeda, K. Kajinami, T. Wakasugi, J. Koizumi, R. Takeda, and C. Asagami. 1989. A young type III hyperlipoproteinemic patient associated with apolipoproteinemic patient associated with apolipoprotein E deficiency. Metab. Clin. Exp. 38:115-119.
7. Kurosaka, D., T. Teramoto, T. Matsushima, T. Yokoyama, A. Yamanda, T. Aikawa, Y. Miyamoto, and K. Kurokawa. 1991. Apolipoprotein E deficiency with a depressed mRNA of normal size. Atherosclerosis. 88:15-20.
8. Feussner, G., J. Dobmeyer, H.J. Grone, S. Lohmer, and S. Wohlfeil. 1996. A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia. Am. J. Hum. Genet. 58:281-291.
9. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
10. Zhang, S., R. Reddick, J. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Wash. DC). 258:468-471.
11. Rall, S.C., Jr., and R.W. Mahley. 1992. The role of apolipopreotein E genetic variants in lipoprotein disorders. (Review.) J. Intern. Merd. 231:653-659.
12. Davignon, J., R.E. Gregg, and C.F. Sing. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1-21.
13. Wilson, P.W.F., R.H. Myers, M.G. Larson, J.M. Ordovas, P.A. Wolf, and E.J. Schaefer. 1994. Apolipoprotein E Alleles, Dyslipidemia, and coronary heart disease. JAMA. 272:1666-1671.
14. Brewer, H.B., Jr., L.A. Zech, R.E. Gregg, D. Schwartz, and E.J. Schaefer. 1983. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann. Intern. Med. 98:623-640.
15. Gregg, R.E., L.A. Zech, E.J. Schaefer, and H.B. Brewer, Jr. 1981. Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science (Wash. DC). 211:584-586.
16. Gregg, R.E., L.A. Zech, E.J. Schaefer, D. Stark, D. Wilson, and H.B. Brewer, Jr. 1986. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest. 78:815-821.
17. Weisgraber, K.H., T.L. Innerarity, and R.W. Mahley. 1982. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257:2518-2521.
18. Wilson, J.M. 1996. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334:1185-1187.
19. Stevenson, S., J. Marshall-Neff, B. Teng, C. Lee, S. Roy, and A. McClelland. 1995. Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer. Arteriosclerosis Thromb. Vasc. Biol. 15:479-484.
20. Kashyap, V.S., S. Santamarina-Fojo, D.R. Brown, C.L. Parrott, D. Applebaum-Bowden, S. Meyn, G. Talley, B. Paigen, N. Maeda, and H.B. Brewer, Jr. 1995. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J. Clin. Invest. 96:1612-1620.
21. Yang, Y., F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol, and J.M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:4407-4411.
22. Yang, Y., H.C.J. Ert, and J.M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1:433-442.
23. Engelhardt, J.F., X. Ye, B. Doranz, and J.M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA. 91: 6196-6200.
24. Ye, X., M. Robinson, M. Batshaw, E. Furth, I. Smith, and J.M. Wilson. 1996. Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J. Biol. Chem. 271:3639-3646.
25. Sambrook, J., E.F. Fritsch, and T. Maniatus. 1989. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
26. Harlow, E., and D. Lane. 1988. Antibodies, A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
27. Tsukamoto, K., T. Watanabe, T. Matsushima, M. Kinoshita, H. Kato, Y. Hashimoto, K. Kurokawa, and T. Teramoto. 1993. Determination by PCR-RFLP of apo E genotype in a Japanese population. J. Lab. Clin. Med. 121:598-602.
28. Kozarsky, K.F., and J.M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Gene. Dev. 3:499-503.
29. Menzel, H.-J., and G. Utermann. 1986. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis. 7:492-495.
30. Gerdes, L.U., C. Gerdes, I.C. Klausen, and O. Faergeman. 1992. Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns. Clin. Chim. Acta. 205:1-9.
31. Herz, J., and R.D. Gerard. 1993. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90:2812-2816.
32. Leiden, J.M. 1996. Adenovirus-mediated gene transfer as an in vivo probe of lipoprotein metabolism. Circulation. 94:2046-2051.
33. Havel, R.J. 1984. The formation of LDL: mechanism and regulation. J. Lipid Res. 25:1570-1576.
34. Ehnholm, C., R.W. Mahley, D.A. Chappell, K.H. Weisgraber, E. Ludwig, and J.L. Witztum. 1984. Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. USA. 81:5566-5570.
35. Linton, M.F., J.B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science (Wash. DC). 267:1034-1037.
36. Vilquin, J.T., B. Guerette, I. Kinoshita, B. Roy, M. Goulet, C. Gravel, R. Roy, and J.P. Tremblay. 1995. FK506 imunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6:1391-1401.
37. Imler, J.L. 1995. Adenovirus vectors as recombinant viral vaccines. (Review.) Vaccine. 13:1143-1151.
38. Kozarsky, K.F., K. Jooss, M. Donahee, J.F. Strauss III, and J.M. Wilson. 1996. Effective treatment of familial hypercholesterolemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nature Genet. 13:54-62.